19 April 2024
The list of vital and essential medicines has been supplemented with new items. The list includes three combination drugs for the treatment of various viral and bacterial infections and infectious and inflammatory diseases. Both lists also include two new drugs from Biocad for patients with multiple sclerosis. All drugs included in the lists are produced in a full cycle in Russia.
The updated list now includes three combination drugs used to treat patients with a range of viral and bacterial infections, as well as infectious and inflammatory diseases. This:
cefepime + sulbactam,
lamivudine + phosphazide,
tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate.
In addition, the list of vital and essential drugs includes two new drugs needed by patients with multiple sclerosis:
sampeginterferon beta-1a, BCD-054,
divosilimab.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025
Long-term potential revealed for novel modifier gene therapy
21 January 2025
Binnopharm Group opened an office in Vietnam
21 January 2025